|
1003
|
3198
|
3vkgA |
X-ray structure of an mtbd truncation mutant of dynein motor domain |
|
899
|
3218
|
3vkhA |
X-ray structure of a functional full-length dynein motor domain |
|
804
|
2695
|
4akgA |
Dynein motor domain - atp complex |
|
807
|
2695
|
4ai6A |
Dynein motor domain - adp complex |
|
798
|
2695
|
4akhA |
Dynein motor domain - amppnp complex |
|
798
|
2695
|
4akiA |
Dynein motor domain - luac derivative |
|
24
|
121
|
1jspB |
Nmr structure of cbp bromodomain in complex with p53 peptide |
|
28
|
118
|
1jm4B |
Nmr structure of p/caf bromodomain in complex with hiv-1 tat peptide |
|
45
|
103
|
1f68A |
Nmr solution structure of the bromodomain from human gcn5 |
|
58
|
205
|
3u5nA |
Crystal structure of the complex of trim33 phd-bromo and h3(1-20)k9me3k14ac histone peptide |
|
44
|
127
|
3u5jA |
Crystal structure of the first bromodomain of human brd4 in complex with alprazolam |
|
56
|
204
|
3u5pA |
Crystal structure of the complex of trim33 phd-bromo and h3(1-28)k9me3k14ack18ack23ac histone peptide |
|
43
|
117
|
3svhA |
Crystal structure of the bromdomain of human crebbp in complex with a 3,5-dimethylisoxazol ligand |
|
47
|
127
|
5luuA |
Structure of the first bromodomain of brd4 with a pyrazolo[4,3-c]pyridin fragment |
|
38
|
108
|
5lvqA |
Crystal structure of human pcaf bromodomain in complex with compound-d (cpd-d), n-methyl-2-(tetrahydro-2h-pyran-4-yloxy)benzamide |
|
173
|
561
|
5lktA |
Crystal structure of the p300 acetyltransferase catalytic core with butyryl-coenzyme a. |
|
43
|
127
|
5lj1A |
N-terminal bromodomain of human brd4 with 8-(((3r,4r,5s)-3-((4,4-difluorocyclohexyl)methoxy)-5-methoxypiperidin-4-yl)amino)-3-methyl-5-(5-methylpyridin-3-yl)-1,7-naphthyridin-2(1h)-one |
|
41
|
108
|
5lvrA |
Crystal structure of human pcaf bromodomain in complex with compound-e (cpd-e) |
|
39
|
116
|
5l8uA |
Crystal structure of baz2b bromodomain in complex with 3-amino-2-methylpyridine derivative 5 |
|
170
|
560
|
5lkxA |
Crystal structure of the p300 acetyltransferase catalytic core with propionyl-coenzyme a. |
|
44
|
127
|
5lj2A |
N-terminal bromodomain of human brd4 with 5-(5-aminopyridin-3-yl)-8-(((3r,4r)-3-((1,1-dioxidotetrahydro-2h-thiopyran-4-yl)methoxy)piperidin-4-yl)amino)-3-methyl-1,7-naphthyridin-2(1h)-one |
|
54
|
130
|
5lj0A |
Crystal structure of human atad2 bromodomain in complex with 8-(((3r,4r,5s)-3-((4,4-difluorocyclohexyl)methoxy)-5-methoxypiperidin-4-yl)amino)-3-methyl-5-(5-methylpyridin-3-yl)-1,7-naphthyridin-2(1h)-one |
|
40
|
116
|
5l8tA |
Crystal structure of baz2b bromodomain in complex with 3-amino-2-methylpyridine derivative 2 |
|
164
|
561
|
5lkzA |
Crystal structure of the p300 acetyltransferase catalytic core with crotonyl-coenzyme a. |
|
39
|
116
|
5l99A |
Crystal structure of baz2b bromodomain in complex with 3-amino-2-methylpyridine derivative 6 |
|
166
|
558
|
5lkuA |
Crystal structure of the p300 acetyltransferase catalytic core with coenzyme a. |
|
42
|
114
|
5ktxA |
Crebbp bromodomain in complex with cpd59 ((s)-1-(3-((2-fluoro-4-(1-methyl-1h-pyrazol-4-yl)phenyl)amino)-1-(tetrahydrofuran-3-yl)-6,7-dihydro-1h-pyrazolo[4,3-c]pyridin-5(4h)-yl)ethanone) |
|
42
|
126
|
5ku3A |
Brd4 bromodomain in complex with cpd59 ((s)-1-(3-((2-fluoro-4-(1-methyl-1h-pyrazol-4-yl)phenyl)amino)-1-(tetrahydrofuran-3-yl)-6,7-dihydro-1h-pyrazolo[4,3-c]pyridin-5(4h)-yl)ethanone) |
|
37
|
114
|
5ktwA |
Crebbp bromodomain in complex with cpd 44 (3-((5-acetyl-1-(cyclopropylmethyl)-4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridin-3-yl)amino)-n-isopropylbenzamide) |
|
41
|
101
|
5ko4A |
Bromodomain from trypanosoma brucei tb427.10.8150 |
|
35
|
100
|
5ji8A |
Crystal structure of the brd9 bromodomain and hit 1 |
|
36
|
119
|
5k29A |
Trypanosoma brucei bromodomain bdf5 (tb427tmp.01.5000) |
|
38
|
110
|
5jwmA |
Bivalent bet bromodomain inhibition |
|
41
|
117
|
5j0dA |
Crystal structure of the bromodomain of human crebbp in complex with a benzoxazepine compound |
|
56
|
139
|
5iglA |
Crystal structure of the second bromodomain of human taf1l in complex with bromosporine (bsp) |
|
41
|
113
|
5ignA |
Crystal structure of human brd9 bromodomain in complex with lp99 chemical probe |
|
41
|
113
|
5igmA |
Crystal structure of the bromodomain of human brd9 in complex with bromosporine (bsp) |
|
44
|
127
|
5igkA |
Crystal structure of the first bromodomain of human brd4 in complex with bromosporine (bsp) |
|
40
|
115
|
5iidA |
Crystal structure of the fifth bromodomain of human polybromo (pb1) in complex with 2-(3,4-dihydroxyphenyl)-5-hydroxy-4h-chromen-4-one |
|
43
|
126
|
5i88A |
Brd4 in complex with cpd4 ((e)-3-(6-(but-2-en-1-yl)-7-oxo-6,7-dihydro-1h-pyrrolo[2,3-c]pyridin-4-yl)-n,n-dimethylbenzamide) |
|
43
|
126
|
5i80A |
Brd4 in complex with cpd2 (n,n-dimethyl-3-(6-methyl-7-oxo-6,7-dihydro-1h-pyrrolo[2,3-c]pyridin-4-yl)benzamide) |
|
35
|
101
|
5i7yA |
Brd9 in complex with cpd4 ((e)-3-(6-(but-2-en-1-yl)-7-oxo-6,7-dihydro-1h-pyrrolo[2,3-c]pyridin-4-yl)-n,n-dimethylbenzamide) |
|
54
|
139
|
5i29A |
Taf1(2) bound to a pyrrolopyridone compound |
|
41
|
115
|
5i86A |
Crystal structure of the bromodomain of human crebbp bound to the benzodiazepinone g02778174 |
|
40
|
114
|
5i83A |
Crystal structure of the bromodomain of human crebbp bound to the benzodiazepinone g02773986 |
|
37
|
102
|
5i40A |
Brd9 in complex with cpd1 (6-methyl-1,6-dihydro-7h-pyrrolo[2,3-c]pyridin-7-one) |
|
56
|
135
|
5i1qA |
Second bromodomain of taf1 bound to a pyrrolopyridone compound |
|
46
|
127
|
5hq5A |
Crystal structure of fragment bound with brd4 |
|
37
|
110
|
5hrxA |
Crystal structure of the fifth bromodomain of human pb1 in complex with 1-butylisochromeno[3,4-c]pyrazol-5(2h)-one) compound |
|
35
|
110
|
5hrwA |
Crystal structure of the fifth bromodomain of human pb1 in complex with 1-propylisochromeno[3,4-c]pyrazol-5(2h)-one) compound |
